Dermatology Billing Built Around Modifier and Coding Precision.
Dermatology billing carries some of the closest payer and federal scrutiny of any specialty — same-day E/M and procedure billing, staged Mohs surgery coding, and the cosmetic-vs-medical distinction all have to be handled correctly, every time. MedVersify's dermatology billing team is trained on exactly these rules.
Dermatology Billing Is Under Real, Documented Scrutiny
10%
Same-Day E/M Claims Failed Federal Review
An HHS-OIG audit of Medicare Part B claims billing an E/M visit alongside a minor dermatologic procedure on the same day found 10 of 100 sampled claims did not meet requirements — projecting an estimated $62.9 million in overpayments nationwide.
HHS-OIG Report A-04-21-04083 (2025)
640%
Growth in Skin-Substitute Billing
Medicare Part B spending on skin substitutes — used heavily in dermatology and wound care — rose from roughly $400 million to nearly $3 billion per quarter, exceeding $10 billion in 2024, a pattern OIG flags for fraud and payment-integrity risk.
HHS-OIG Data Brief OEI-BL-24-00420 (2025)
2023–25
Claim Years Under Active OIG Review
OIG's 2026 Work Plan added a review of Part B claims where an E/M service was paid alongside a minor procedure with no modifier 25 attached — a billing pattern dermatology practices generate constantly.
HHS-OIG Work Plan (added March 2026)
17311–315
Mohs Surgery Code Range
CMS's coverage policy for Mohs micrographic surgery bundles the pathology and margin exam into the Mohs code itself — billing it as a separate service is a common, avoidable denial trigger.
CMS Medicare Coverage Database (LCD)
Generic Billing Processes Miss What Dermatology Actually Requires
Which is exactly why medical billing done right has to start with specialty-specific coding knowledge, not a one-size-fits-all claims process.
The cosmetic-vs-medical line has to be documented, not assumed
The same procedure — a mole removal, a lesion excision — can be a patient-pay cosmetic service or an insurance-billable medical service depending entirely on documented medical necessity. Get the classification wrong and you either lose collectible insurance revenue or create a compliance exposure that draws exactly the kind of federal attention noted above.
Modifier 25 is under direct federal scrutiny
CMS declined to add blanket new regulation on dermatologists after its 90/100 compliance finding, but that doesn't mean the scrutiny stopped — OIG's active work plan review means every same-day E/M-plus-procedure claim needs documentation that actually supports a separately identifiable visit, not just a checked box.
Mohs surgery is staged, not flat-rate
CPT 17311–17315 bill by stage and tissue block, with the pathology exam bundled into the surgeon-pathologist's own code. Billing pathology separately, or miscounting stages, are two of the most common — and most preventable — Mohs claim errors.
Biopsy, destruction, and excision are coded — and paid — differently
A shave biopsy, a punch biopsy, a lesion destruction, and a full excision each map to different CPT families with different global periods, different lesion-count and lesion-size rules, and different documentation expectations. Using the wrong family changes reimbursement and creates an audit flag if it happens repeatedly.
Skin-substitute billing is now a named fraud-risk area
If your practice uses skin substitutes for chronic wound or ulcer care alongside dermatology services, be aware that OIG has specifically flagged this product category for rapid spending growth and fraud-risk billing patterns — claims here need tighter documentation and coding discipline than routine procedures.
Teledermatology billing is narrower than it looks
Live video dermatology visits generally follow standard telehealth billing rules, but asynchronous "store-and-forward" consults — a common dermatology workflow — are not broadly reimbursed by Medicare Part B the same way. Outside specific interprofessional consult codes, async workflows need a deliberately designed billing approach, not an assumption that it works like a video visit.
Pathology has to tie back to the billed diagnosis
When a lesion is sent for pathology, the final ICD-10 diagnosis on the claim should reflect the pathology result, not just the pre-op clinical impression. A mismatch between the two is a documentation gap payers are trained to catch.
Common Dermatology Billing Codes
Skin Biopsy
Tangential/shave (11102), punch (11104), and incisional (11106) biopsy, each with an add-on code (11103/11105/11107) for additional lesions in the same encounter.
Destruction, Premalignant Lesions
Actinic keratosis and similar premalignant lesion destruction — the first lesion is billed separately from each additional lesion.
Destruction, Benign Lesions
Split by lesion count — up to 14 lesions versus 15 or more — regardless of anatomic location.
Destruction, Malignant Lesions
Split by body region (trunk/arms/legs, scalp/neck/hands/feet/genitalia, face/ears/eyelids/nose/lips) and lesion size — three separate code families, not one range.
Lesion Excision, Benign & Malignant
Excision codes split by anatomic region and lesion size, with a separate code family for benign versus malignant pathology.
Mohs Micrographic Surgery
Billed by stage and tissue block; the pathology and margin exam performed by the surgeon-pathologist is bundled into the Mohs code itself.
The Denial Patterns Dermatology Practices See Most
Missing Modifier 25 Support
A same-day E/M and minor procedure billed together without documentation showing the E/M was a significant, separately identifiable service — exactly the pattern federal reviewers are actively auditing.
MedVersify Approach
We review same-day E/M-plus-procedure documentation before submission, not after a denial or audit letter arrives.
Pathology-to-Diagnosis Mismatch
The billed ICD-10 diagnosis reflects the pre-op clinical impression rather than the final pathology result, creating a documentation gap payers are specifically trained to flag.
MedVersify Approach
We reconcile pathology reports against billed diagnosis codes before claims go out.
Incorrect Lesion Count or Size
Destruction and excision codes are split by lesion count and measured size — a miscount or missing measurement is one of the most common, entirely preventable coding errors in dermatology.
MedVersify Approach
Documentation is checked against the specific code family's lesion-count and size rules before submission.
How MedVersify Handles Dermatology Billing
Coding & Modifier Audit
We review current claims for modifier 25 patterns, Mohs staging accuracy, and cosmetic-vs-medical classification before anything else changes.
Documentation Alignment
Clinical notes, pathology results, and billed diagnosis codes are checked for consistency so medical necessity is supported on paper, not just in practice.
High-Risk Code Compliance Check
Mohs staging, skin-substitute claims, and biopsy-versus-excision coding are given extra review given the level of federal attention each currently draws.
Claim Submission & Tracking
Every claim — procedural, E/M, and pathology-linked — is scrubbed, submitted, and tracked to acceptance, with same-day correction on clearinghouse rejections.
Denial Management & Appeals
Medical-necessity and modifier-related denials are categorized, corrected, and appealed with the documentation payers actually ask for — not a generic resubmission.
Medical Billing Denial Management: How to Cut Your Denial Rate Below 5% in 2025
The CARC codes and prevention system behind fewer denials — including the medical-necessity patterns dermatology claims see often.
Read article Medical BillingMedical Billing for Small Practices: The Complete 2026 Guide
Most dermatology practices run lean — this guide covers the KPIs and outsourcing math independent practices need.
Read articleMedVersify Dermatology Billing
Billing That Understands Modifiers, Mohs, and Medical Necessity.
Nationwide dermatology billing support, from solo practices to multi-provider surgical groups.